HER2/ErbB2 antibody | knockout validation | Cell Signaling 2165

This is a knockout-validated antibody summary, based on the publication "Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer Cells", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Cell Signaling

Antibody: HER2/ErbB2

Catalog number: 2165

Summary: Rabbit monoclonal antibody against a synthetic peptide corresponding to residues surrounding tyrosine 1248 of human ErbB2 protein. Reacts with human and mouse. It is predicted to react based on 100% sequence homology with rat. Suitable for western blot, immunoprecipitation, immunohistochemistry (paraffin), immunofluorescence/immunocytochemistry and flow cytometry (fixed/permeabilized).

Validation Method

Western blot

Sample

Control and ERBB2-KO SKBR3 cells.

Secondary incubation

Goat anti-rabbit IgG (H+L)–HRP conjugate (Bio-Rad Laboratories, 170–6515).

References
  1. Chen Y, Wang R, Huang S, Henson E, Bi J, Gibson S. Erb-b2 Receptor Tyrosine Kinase 2 (ERBB2) Promotes ATG12-Dependent Autophagy Contributing to Treatment Resistance of Breast Cancer Cells. Cancers (Basel). 2021;13: pubmed publisher